{"transactions":[{"id":832393,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:05:04.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":135000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on March 19, 2026. The shares underlying the option are scheduled to vest over four years, with 25% of the shares underlying the option vesting on March 19, 2027, and the remainder vesting in equal monthly installments thereafter, subject to continuous service."}],"balance_after":135000,"derivative":{"exercise_price":6.81,"expiration_date":"2036-03-18","underlying":"Common Stock","underlying_shares":135000},"source":{"system":"sec-edgar","filing":"0001193125-26-117616","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000119312526117616/ownership.xml","form_type":"4"}},{"id":1173315,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-11T20:52:08.000Z","date":"2025-04-10","kind":"grant","planned":false,"acquired":true,"shares":101000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted on April 10, 2025. The shares underlying the option are scheduled to vest over four years, with 25% of the shares underlying the option vesting on March 18, 2026, and the remainder vesting in equal monthly installments thereafter, subject to continuous service."}],"balance_after":101000,"derivative":{"exercise_price":7.31,"expiration_date":"2035-04-09","underlying":"Common Stock","underlying_shares":101000},"source":{"system":"sec-edgar","filing":"0000950170-25-053338","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000095017025053338/ownership.xml","form_type":"4"}},{"id":1173314,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-11T20:52:08.000Z","date":"2025-04-10","kind":"grant","planned":false,"acquired":true,"shares":70551,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on April 10, 2025. The shares underlying the option are scheduled to vest over four years, with 25% of the shares underlying the option vesting on December 31, 2025, and the remainder vesting in equal monthly installments thereafter, subject to continuous service."}],"balance_after":70551,"derivative":{"exercise_price":7.31,"expiration_date":"2035-04-09","underlying":"Common Stock","underlying_shares":70551},"source":{"system":"sec-edgar","filing":"0000950170-25-053338","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000095017025053338/ownership.xml","form_type":"4"}},{"id":1200003,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-18T21:43:41.000Z","date":"2025-03-18","kind":"grant","planned":false,"acquired":true,"shares":28224,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"Stock option assumed in connection with the closing of the Merger, in exchange for an outstanding option to purchase shares of KTx pursuant to the terms and conditions of the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, as of the effective time of the Merger, each share of KTx common stock was converted into and became exchangeable for the right to receive 0.2016 shares of common stock of the Issuer (the \"Exchange Ratio\") and each outstanding option to purchase shares of KTx common stock, whether or not vested, was converted into an option to acquire shares of common stock of the Issuer, with necessary adjustments to the number of shares and exercise price to reflect the Exchange Ratio, on the same terms and conditions as were applicable immediately prior to the effective time of the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vests over four years beginning on the vesting commencement date of June 17, 2024, with 1/48th the shares underlying the option vesting at the end of each successive one-month period thereafter."}],"balance_after":28224,"derivative":{"exercise_price":0.85,"expiration_date":"2034-07-22","underlying":"Common Stock","underlying_shares":28224},"source":{"system":"sec-edgar","filing":"0000950170-25-041494","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000095017025041494/ownership.xml","form_type":"4"}},{"id":1200002,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-03-18T21:43:41.000Z","date":"2025-03-18","kind":"grant","planned":false,"acquired":true,"shares":4030,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Shares issued upon closing of the transactions contemplated by the Agreement and Plan of Merger, dated as of November 7, 2024 (the \"Merger Agreement\"), by and among the Issuer, Aurora Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of the Issuer, and Kalaris Tx, Inc. (previously named Kalaris Therapeutics, Inc.), a Delaware corporation (\"KTx\"), in exchange for outstanding shares of KTx pursuant to the terms and conditions of the Merger Agreement (such transaction, the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, as of the effective time of the Merger, each share of KTx common stock was converted into and became exchangeable for the right to receive 0.2016 shares of common stock of the Issuer (the \"Exchange Ratio\") and each outstanding option to purchase shares of KTx common stock, whether or not vested, was converted into an option to acquire shares of common stock of the Issuer, with necessary adjustments to the number of shares and exercise price to reflect the Exchange Ratio, on the same terms and conditions as were applicable immediately prior to the effective time of the Merger."}],"balance_after":4030,"source":{"system":"sec-edgar","filing":"0000950170-25-041494","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000095017025041494/ownership.xml","form_type":"4"}},{"id":3452175,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Global Strat. & Dev."}}],"security":"Stock Option (right to buy)","published_at":"2019-07-31T20:28:19.000Z","date":"2019-07-29","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option becomes exercisable based on the achievement of certain performance milestones. For each milestone met, the option vests as to 16,666.6667 shares of the Company's common stock in accordance with the following schedule: 25% of the underlying shares for such milestone vest on achievement of such milestone, and thereafter the remaining underlying shares for such milestone vest in equal monthly installments over three years, resulting in the option being exercisable for 100% of the underlying shares for such milestone on the third anniversary of the achievement of the applicable milestone."}],"balance_after":100000,"derivative":{"exercise_price":3.91,"expiration_date":"2029-07-29","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001273636-19-000022","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1716950/000127363619000022/edgar.xml","form_type":"4"}},{"id":3461975,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-07-15T16:45:53.000Z","date":"2019-07-11","kind":"tax_withholding","acquired":false,"shares":592,"price":3.75,"value":2220.0,"ownership":{"direct":true},"balance_after":56052,"source":{"system":"sec-edgar","filing":"0001273636-19-000019","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1716950/000127363619000019/edgar.xml","form_type":"4"}},{"id":3461974,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-07-15T16:45:53.000Z","date":"2019-07-11","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock vested immediately upon grant."}],"balance_after":56644,"source":{"system":"sec-edgar","filing":"0001273636-19-000019","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1716950/000127363619000019/edgar.xml","form_type":"4"}},{"id":3482559,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-06-20T16:39:03.000Z","date":"2019-06-11","kind":"tax_withholding","acquired":false,"shares":685,"price":3.7,"value":2534.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4/A is being filed to correct an administrative error in the reported price of the securities forfeited for tax witholding purposes."}],"balance_after":54644,"source":{"system":"sec-edgar","filing":"0001273636-19-000017","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1716950/000127363619000017/edgar.xml","form_type":"4/A","original_submission_date":"2019-06-13"}},{"id":3491484,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-06-13T19:21:04.000Z","date":"2019-06-11","kind":"tax_withholding","acquired":false,"shares":685,"price":3.77,"value":2582.45,"ownership":{"direct":true},"balance_after":54644,"source":{"system":"sec-edgar","filing":"0001273636-19-000015","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1716950/000127363619000015/edgar.xml","form_type":"4"}},{"id":3491483,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-06-13T19:21:04.000Z","date":"2019-06-11","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock vested immediately upon grant."}],"balance_after":55329,"source":{"system":"sec-edgar","filing":"0001273636-19-000015","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1716950/000127363619000015/edgar.xml","form_type":"4"}},{"id":3518735,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-05-20T16:02:37.000Z","date":"2019-05-13","kind":"tax_withholding","acquired":false,"shares":685,"price":4.06,"value":2781.1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4/A is being filed to correct an administrative error in the reported price of the securities forfeited for tax witholding purposes."}],"balance_after":53329,"source":{"system":"sec-edgar","filing":"0001273636-19-000011","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1716950/000127363619000011/edgar.xml","form_type":"4/A","original_submission_date":"2019-05-15"}},{"id":3526150,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-05-15T16:21:27.000Z","date":"2019-05-13","kind":"tax_withholding","acquired":false,"shares":685,"price":4.2,"value":2877.0,"ownership":{"direct":true},"balance_after":53329,"source":{"system":"sec-edgar","filing":"0001273636-19-000010","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1716950/000127363619000010/edgar.xml","form_type":"4"}},{"id":3526149,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-05-15T16:21:27.000Z","date":"2019-05-13","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock vested immediately upon grant."}],"balance_after":54014,"source":{"system":"sec-edgar","filing":"0001273636-19-000010","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1716950/000127363619000010/edgar.xml","form_type":"4"}},{"id":3555860,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-04-15T17:42:04.000Z","date":"2019-04-11","kind":"tax_withholding","acquired":false,"shares":606,"price":4.61,"value":2793.66,"ownership":{"direct":true},"balance_after":52014,"source":{"system":"sec-edgar","filing":"0001273636-19-000009","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1716950/000127363619000009/edgar.xml","form_type":"4"}},{"id":3555859,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-04-15T17:42:04.000Z","date":"2019-04-11","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock vested immediately upon grant."}],"balance_after":52620,"source":{"system":"sec-edgar","filing":"0001273636-19-000009","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1716950/000127363619000009/edgar.xml","form_type":"4"}},{"id":3597266,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-03-13T17:16:17.000Z","date":"2019-03-11","kind":"tax_withholding","acquired":false,"shares":667,"price":3.97,"value":2647.99,"ownership":{"direct":true},"balance_after":50620,"source":{"system":"sec-edgar","filing":"0001273636-19-000008","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1716950/000127363619000008/edgar.xml","form_type":"4"}},{"id":3597265,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-03-13T17:16:17.000Z","date":"2019-03-11","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock vested immediately upon grant."}],"balance_after":51287,"source":{"system":"sec-edgar","filing":"0001273636-19-000008","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1716950/000127363619000008/edgar.xml","form_type":"4"}},{"id":3660600,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-02-13T18:30:38.000Z","date":"2019-02-11","kind":"tax_withholding","acquired":false,"shares":791,"price":3.29,"value":2602.39,"ownership":{"direct":true},"balance_after":49287,"source":{"system":"sec-edgar","filing":"0001273636-19-000006","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1716950/000127363619000006/edgar.xml","form_type":"4"}},{"id":3660599,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-02-13T18:30:38.000Z","date":"2019-02-11","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock vested immediately upon grant."}],"balance_after":50078,"source":{"system":"sec-edgar","filing":"0001273636-19-000006","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1716950/000127363619000006/edgar.xml","form_type":"4"}},{"id":3695592,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-01-15T19:58:03.000Z","date":"2019-01-11","kind":"tax_withholding","acquired":false,"shares":713,"price":3.2,"value":2281.6,"ownership":{"direct":true},"balance_after":48078,"source":{"system":"sec-edgar","filing":"0001273636-19-000003","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1716950/000127363619000003/edgar.xml","form_type":"4"}},{"id":3695591,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-01-15T19:58:03.000Z","date":"2019-01-11","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock vested immediately upon grant."}],"balance_after":48791,"source":{"system":"sec-edgar","filing":"0001273636-19-000003","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1716950/000127363619000003/edgar.xml","form_type":"4"}},{"id":3732314,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-12-13T21:23:26.000Z","date":"2018-12-11","kind":"tax_withholding","acquired":false,"shares":611,"price":6.11,"value":3733.21,"ownership":{"direct":true},"balance_after":46791,"source":{"system":"sec-edgar","filing":"0001273636-18-000077","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1716950/000127363618000077/edgar.xml","form_type":"4"}},{"id":3732313,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-12-13T21:23:26.000Z","date":"2018-12-11","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock vested immediately upon grant."}],"balance_after":47402,"source":{"system":"sec-edgar","filing":"0001273636-18-000077","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1716950/000127363618000077/edgar.xml","form_type":"4"}},{"id":3764806,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-11-14T16:43:30.000Z","date":"2018-11-12","kind":"tax_withholding","acquired":false,"shares":685,"price":7.05,"value":4829.25,"ownership":{"direct":true},"balance_after":45402,"source":{"system":"sec-edgar","filing":"0001273636-18-000060","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1716950/000127363618000060/edgar.xml","form_type":"4"}},{"id":3764805,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-11-14T16:43:30.000Z","date":"2018-11-12","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock vested immediately upon grant."}],"balance_after":46087,"source":{"system":"sec-edgar","filing":"0001273636-18-000060","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1716950/000127363618000060/edgar.xml","form_type":"4"}},{"id":3790689,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-10-15T19:01:56.000Z","date":"2018-10-11","kind":"tax_withholding","acquired":false,"shares":612,"price":6.46,"value":3953.52,"ownership":{"direct":true},"balance_after":44087,"source":{"system":"sec-edgar","filing":"0001273636-18-000058","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1716950/000127363618000058/edgar.xml","form_type":"4"}},{"id":3790688,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-10-15T19:01:56.000Z","date":"2018-10-11","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock vested immediately upon grant."}],"balance_after":44699,"source":{"system":"sec-edgar","filing":"0001273636-18-000058","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1716950/000127363618000058/edgar.xml","form_type":"4"}},{"id":3817101,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-09-13T17:04:27.000Z","date":"2018-09-11","kind":"tax_withholding","acquired":false,"shares":685,"price":3.925,"value":2688.625,"ownership":{"direct":true},"balance_after":42699,"source":{"system":"sec-edgar","filing":"0001273636-18-000051","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1716950/000127363618000051/edgar.xml","form_type":"4"}},{"id":3817100,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-09-13T17:04:27.000Z","date":"2018-09-11","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock vested immediately upon grant."}],"balance_after":43384,"source":{"system":"sec-edgar","filing":"0001273636-18-000051","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1716950/000127363618000051/edgar.xml","form_type":"4"}},{"id":3843476,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-08-15T19:07:47.000Z","date":"2018-08-13","kind":"tax_withholding","acquired":false,"shares":592,"price":4,"value":2368.0,"ownership":{"direct":true},"balance_after":41384,"source":{"system":"sec-edgar","filing":"0001273636-18-000049","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1716950/000127363618000049/edgar.xml","form_type":"4"}},{"id":3843475,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-08-15T19:07:47.000Z","date":"2018-08-13","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock vested immediately upon grant."}],"balance_after":41976,"source":{"system":"sec-edgar","filing":"0001273636-18-000049","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1716950/000127363618000049/edgar.xml","form_type":"4"}},{"id":3868036,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-07-13T17:57:47.000Z","date":"2018-07-11","kind":"tax_withholding","acquired":false,"shares":685,"price":4.15,"value":2842.75,"ownership":{"direct":true},"balance_after":39976,"source":{"system":"sec-edgar","filing":"0001273636-18-000009","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1716950/000127363618000009/edgar.xml","form_type":"4"}},{"id":3868035,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-07-13T17:57:47.000Z","date":"2018-07-11","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock vested immediately upon grant."}],"balance_after":40661,"source":{"system":"sec-edgar","filing":"0001273636-18-000009","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1716950/000127363618000009/edgar.xml","form_type":"4"}},{"id":3895606,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-06-13T19:33:09.000Z","date":"2018-06-11","kind":"tax_withholding","acquired":false,"shares":606,"price":4.55,"value":2757.3,"ownership":{"direct":true},"balance_after":38661,"source":{"system":"sec-edgar","filing":"0001716950-18-000019","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1716950/000171695018000019/edgar.xml","form_type":"4"}},{"id":3895605,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-06-13T19:33:09.000Z","date":"2018-06-11","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock vested immediately upon grant."}],"balance_after":39267,"source":{"system":"sec-edgar","filing":"0001716950-18-000019","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1716950/000171695018000019/edgar.xml","form_type":"4"}},{"id":3925972,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-05-18T18:17:33.000Z","date":"2018-05-16","kind":"tax_withholding","acquired":false,"shares":3425,"price":5.6,"value":19180.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares forfeited in connection with tax withholding as a result of vesting of restricted stock awarded on March 28, 2018."}],"balance_after":37267,"source":{"system":"sec-edgar","filing":"0001716950-18-000017","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1716950/000171695018000017/edgar.xml","form_type":"4"}},{"id":3933128,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-05-15T16:34:41.000Z","date":"2018-05-11","kind":"tax_withholding","acquired":false,"shares":685,"price":4.9,"value":3356.5,"ownership":{"direct":true},"balance_after":40692,"source":{"system":"sec-edgar","filing":"0001716950-18-000015","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1716950/000171695018000015/edgar.xml","form_type":"4"}},{"id":3933127,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-05-15T16:34:41.000Z","date":"2018-05-11","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock vested immediately upon grant."}],"balance_after":41377,"source":{"system":"sec-edgar","filing":"0001716950-18-000015","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1716950/000171695018000015/edgar.xml","form_type":"4"}},{"id":3964055,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-04-13T16:20:02.000Z","date":"2018-04-11","kind":"tax_withholding","acquired":false,"shares":685,"price":4,"value":2740.0,"ownership":{"direct":true},"balance_after":39377,"source":{"system":"sec-edgar","filing":"0001716950-18-000013","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1716950/000171695018000013/edgar.xml","form_type":"4"}},{"id":3964054,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-04-13T16:20:02.000Z","date":"2018-04-11","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock vested immediately upon grant."}],"balance_after":40062,"source":{"system":"sec-edgar","filing":"0001716950-18-000013","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1716950/000171695018000013/edgar.xml","form_type":"4"}},{"id":3967732,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-04-06T20:45:55.000Z","date":"2018-02-09","kind":"tax_withholding","acquired":false,"shares":733,"price":3.95,"value":2895.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This Form 4/A amends the February Form 4 to report the number of shares withheld in connection with the reporting person's tax obligation with respect to the fully vested stock award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This Form 4/A amends the February Form 4 to report the number of shares withheld in connection with the reporting person's tax obligation with respect to the fully vested stock award."}],"balance_after":26729,"source":{"system":"sec-edgar","filing":"0001716950-18-000012","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1716950/000171695018000012/edgar.xml","form_type":"4/A","original_submission_date":"2018-02-13"}},{"id":3967731,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-04-06T20:45:55.000Z","date":"2018-02-09","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This Form 4/A amends the Form 4 previously filed on February 13, 2018 (the \"February Form 4\") in order to correct the transaction date from February 11, 2018 to February 9, 2018."},{"field":"shares","element":"transactionShares","label":"F2","text":"The common stock vested immediately upon grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Such number has been updated to reflect a Form 4 and a Form 4/A, each filed on the date hereof.  The Form 4 reported the number of shares withheld in connection with the reporting person's tax obligation as a result of the vesting of a restricted stock award on December 11, 2017.  The Form 4/A amended a Form 4 filed on January 16, 2018 to correct the number of shares withheld in connection with the reporting person's tax obligation as a result of a fully vested stock award."}],"balance_after":27462,"source":{"system":"sec-edgar","filing":"0001716950-18-000012","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1716950/000171695018000012/edgar.xml","form_type":"4/A","original_submission_date":"2018-02-13"}},{"id":3967730,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-04-06T20:26:28.000Z","date":"2018-01-11","kind":"tax_withholding","acquired":false,"shares":791,"price":4.3,"value":3401.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This Form 4/A amends the Form 4 previously filed on January 16, 2018 to correct the number of shares withheld in connection with the reporting person's tax obligation as a result of the fully vested stock award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This Form 4/A amends the Form 4 previously filed on January 16, 2018 to correct the number of shares withheld in connection with the reporting person's tax obligation as a result of the fully vested stock award."}],"balance_after":25462,"source":{"system":"sec-edgar","filing":"0001716950-18-000010","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1716950/000171695018000010/edgar.xml","form_type":"4/A","original_submission_date":"2018-01-16"}},{"id":3967729,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-04-06T20:26:28.000Z","date":"2018-01-11","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock vested immediately upon grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Such number has been updated to reflect a Form 4 filed on the date hereof that reported the number of shares withheld in connection with the reporting person's tax obligation as a result of the vesting of a restricted stock award on December 11, 2017."}],"balance_after":26253,"source":{"system":"sec-edgar","filing":"0001716950-18-000010","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1716950/000171695018000010/edgar.xml","form_type":"4/A","original_submission_date":"2018-01-16"}},{"id":3967728,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-04-06T20:15:31.000Z","date":"2017-12-11","kind":"tax_withholding","acquired":false,"shares":3395,"price":3.75,"value":12731.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares forfeited in connection with tax withholding as a result of vesting of restricted stock awarded on December 11, 2017."}],"balance_after":24253,"source":{"system":"sec-edgar","filing":"0001716950-18-000008","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1716950/000171695018000008/edgar.xml","form_type":"4"}},{"id":3978810,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-03-30T18:06:19.000Z","date":"2018-03-28","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock shall vest on May 16, 2018, subject to Dr. Feinsod's continued employment."}],"balance_after":42126,"source":{"system":"sec-edgar","filing":"0001716950-18-000005","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1716950/000171695018000005/edgar.xml","form_type":"4"}},{"id":3996495,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-03-14T19:49:24.000Z","date":"2018-03-12","kind":"tax_withholding","acquired":false,"shares":667,"price":4.3,"value":2868.1,"ownership":{"direct":true},"balance_after":32126,"source":{"system":"sec-edgar","filing":"0001716950-18-000003","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1716950/000171695018000003/edgar.xml","form_type":"4"}},{"id":3996494,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-03-14T19:49:24.000Z","date":"2018-03-12","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock vested immediately upon grant."}],"balance_after":32793,"source":{"system":"sec-edgar","filing":"0001716950-18-000003","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1716950/000171695018000003/edgar.xml","form_type":"4"}},{"id":4063056,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-02-13T19:06:07.000Z","date":"2018-02-11","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock vested immediately upon grant."}],"balance_after":30793,"source":{"system":"sec-edgar","filing":"0001716950-18-000001","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1716950/000171695018000001/edgar.xml","form_type":"4"}},{"id":4099451,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-01-16T20:29:39.000Z","date":"2018-01-11","kind":"tax_withholding","acquired":false,"shares":855,"price":4.3,"value":3676.5,"ownership":{"direct":true},"balance_after":28793,"source":{"system":"sec-edgar","filing":"0000899243-18-001111","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1716950/000089924318001111/doc4.xml","form_type":"4"}},{"id":4099450,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-01-16T20:29:39.000Z","date":"2018-01-11","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock vested immediately upon grant."}],"balance_after":29648,"source":{"system":"sec-edgar","filing":"0000899243-18-001111","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1716950/000089924318001111/doc4.xml","form_type":"4"}},{"id":4208433,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":56839,"kind":"person","name":"Feinsod Matthew","position":1,"cik":"0001716950","reported_name":"Feinsod Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-09-15T17:07:58.000Z","date":"2017-09-14","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock shall vest on December 11, 2017, provided that Mr. Feinsod has remained employed as Interim Chief Medical Officer through such date; however, if Applied Genetic Technologies Corporation elects to terminate Mr. Feinsod's employment as Interim Chief Medical Officer on or before December 11, 2017, the shares shall vest on the date of termination."}],"balance_after":27648,"source":{"system":"sec-edgar","filing":"0000899243-17-022152","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1716950/000089924317022152/doc4.xml","form_type":"4"}}]}